Other small molecule CSF-1R inhibitors include ARRY-382, PLX7486, BLZ945 and JNJ-40346527 (edicotinib), and all are currently being evaluated in clinical trials for treatment of Hodgkin lymphoma (cHL) (87). This evidence concerns the gene CSF1R and Hodgkins lymphoma.